Neumora Therapeutics, Inc. Common Stock (NASDAQ: NMRA) last traded at $0.476, down 0.85% on the session. The quote above updates while this page is open; the figures below are drawn from Neumora Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Neumora Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker NMRA. Its market capitalisation is $89.38 million.
Valuation measures for Neumora Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $89.38M |
|---|---|
| Enterprise value | $53.28M |
| Price / book | 2.01 |
| Beta | 0.65 |
Trailing-twelve-month figures tagged in Neumora Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$212.75M |
| EPS (TTM) | -$1.23 |
|---|
| Return on equity | -477.87% |
|---|
| Cash | $116.83M |
|---|
Range and volume for NMRA over the past 52 weeks.
| 52-week high | $3.65 |
|---|---|
| 52-week low | $0.450 |
| Volume | 789.4K |
| Average volume | 1.19M |
| Previous close | $0.480 |
Invest a chosen dollar amount in Neumora Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell NMRA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.